NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.390
0.00 (0.00%)
Apr 29, 2026, 12:06 PM EDT - Market open
NovaBridge Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -88.34 | -22.23 | -207.73 | -371.05 | -367.02 | Upgrade
|
| Depreciation & Amortization | 0.86 | 0.98 | 1.06 | 1.42 | 4.84 | Upgrade
|
| Other Amortization | - | - | - | 2.25 | 0.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | -0.01 | - | -0.03 | 0.05 | Upgrade
|
| Asset Writedown & Restructuring Costs | 42.07 | 1.25 | 23.04 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.75 | - | -0.22 | -1.9 | -4.78 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 1.04 | 11.4 | 64.71 | 57.91 | Upgrade
|
| Stock-Based Compensation | 5.97 | -1.95 | 10.24 | 13.15 | 95.8 | Upgrade
|
| Other Operating Activities | - | -28.93 | 126.63 | 224.78 | -2.21 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 1.55 | 11.18 | Upgrade
|
| Change in Inventory | - | - | - | - | -4.29 | Upgrade
|
| Change in Unearned Revenue | - | - | - | - | 34.08 | Upgrade
|
| Change in Other Net Operating Assets | 17.07 | -2.81 | -37.12 | 15.55 | 21.13 | Upgrade
|
| Operating Cash Flow | -20.6 | -106.63 | -146.5 | -90.22 | -153.18 | Upgrade
|
| Capital Expenditures | -0.01 | -0.05 | -0.16 | -2.09 | -4.71 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.05 | 0.06 | - | - | - | Upgrade
|
| Investment in Securities | 104.93 | -136.03 | -15 | -3.09 | -109.76 | Upgrade
|
| Investing Cash Flow | 104.97 | -136.02 | -15.16 | -5.18 | -114.47 | Upgrade
|
| Issuance of Common Stock | 61.91 | - | 0.41 | 6.92 | 115.31 | Upgrade
|
| Repurchase of Common Stock | - | -0.34 | -8.64 | -3.01 | - | Upgrade
|
| Other Financing Activities | -4.19 | - | - | - | -21.82 | Upgrade
|
| Financing Cash Flow | 57.73 | -0.34 | -8.24 | 3.91 | 93.49 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.28 | 0.57 | 5.2 | 14.2 | -20.27 | Upgrade
|
| Net Cash Flow | 142.37 | -242.4 | -164.7 | -77.3 | -194.43 | Upgrade
|
| Free Cash Flow | -20.6 | -106.68 | -146.66 | -92.32 | -157.89 | Upgrade
|
| Free Cash Flow Margin | - | - | -23206.33% | - | -1139.46% | Upgrade
|
| Free Cash Flow Per Share | -0.21 | -1.31 | -1.76 | -1.12 | -2.08 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.1 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 1.43 | Upgrade
|
| Levered Free Cash Flow | -37.11 | -68.15 | -58.84 | 47.43 | -96.12 | Upgrade
|
| Unlevered Free Cash Flow | -37.11 | -68.15 | -58.84 | 47.43 | -96.12 | Upgrade
|
| Change in Working Capital | 17.07 | -2.81 | -37.12 | 17.09 | 62.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.